Endosc Int Open 2015; 03(04): E346-E353
DOI: 10.1055/s-0034-1391847
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Real-life conditions of use of sodium phosphate tablets for colon cleansing before colonoscopy

Hervé Hagège
1   CHI de Créteil, Service d’Hépato-gastroentérologie, Créteil, France
,
René Laugier
2   Hôpital de la Timone, Service de Gastroentérologie, Marseille, France
,
Stéphane Nahon
3   GHI Le Raincy-Montfermeil, Service de Gastroentérologie, Montfermeil, France
,
Pierre Coulom
4   Clinique Saint-Jean Languedoc, Service de Gastroentérologie et Hépatologie, Toulouse, France
,
Corinne Isnard-Bagnis
5   Service de Néphrologie, Hôpital de la Pitié-Salpêtrière, Paris, France
,
Annaïck Albert-Marty
6   Département de Pharmacovigilance, Mayoly-Spindler, Chatou, France.
› Author Affiliations
Further Information

Publication History

submitted 12 January 2015

accepted after revision 21 January 2015

Publication Date:
05 May 2015 (online)

Background and study aims: The purpose of this study was to describe the real-life conditions of use, efficacy, safety, and acceptability of sodium phosphate (NaP) tablets for colon cleansing in routine medical practice in France.

Patients and methods: A total of 996 patients undergoing bowel preparation were enrolled by 108 gastroenterologists in this observational, longitudinal, prospective, multicenter study. The conditions of use of NaP tablets were assessed with a composite endpoint, which included six criteria for patient compliance with the recommended administration scheme and a criterion for the absence of contraindications to NaP use.

Results: Adequate use of NaP was reported for 75.1 % of the patients. The main reasons for misuse were a smaller fluid intake than expected with a dose of 4 tablets and noncompliance with age-related contraindications. The quality of cleansing was satisfactory: the Boston Bowel Preparation Scale (BBPS) total score was 7 or higher in 75.4 % of the patients. Gastroscopy associated with colonoscopy in 38.9 % of the patients revealed gastric lesions, which were considered as possibly related to the use of NaP tablets in 10.3 % of them. Vomiting occurred in 9.8 % of the patients, and 0.6 % discontinued bowel preparation after an adverse event. No electrolyte disorders or renal impairment was reported, even if not systematically sought. The acceptability of the NaP tablets was high, particularly among patients who previously had undergone other methods of bowel preparation.

Conclusions: Despite being defined according to strict criteria, adequate use of NaP tablets was observed in a high percentage of patients. The quality of colon cleansing and the safety and acceptability of NaP tablets were satisfactory and consistent with data from randomized clinical studies.

 
  • References

  • 1 Quintero E, Castells A, Bujanda L et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012; 366: 697-706
  • 2 Zauber AG, Winawer SJ, O'Brien MJ et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366: 687-696
  • 3 Froehlich F, Wietlisbach V, Gonvers JJ et al. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest Endosc 2005; 61: 378-384
  • 4 Harewood GC, Sharma VK, de Garmo P. Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Gastrointest Endosc 2003; 58: 76-79
  • 5 Rex DK, Imperiale TF, Latinovich DR Bratcher LL. Impact of bowel preparation on efficiency and cost of colonoscopy. Am J Gastroenterol 2002; 97: 1696-1700
  • 6 Tan JJ, Tjandra JJ. Which is the optimal bowel preparation for colonoscopy – a meta-analysis. Colorectal Dis 2006; 8: 247-258
  • 7 Johanson JF, Popp Jr JW, Cohen LB et al. A randomized, multicenter study comparing the safety and efficacy of sodium phosphate tablets with 2L polyethylene glycol solution plus bisacodyl tablets for colon cleansing. Am J Gastroenterol 2007; 102: 2238-2246
  • 8 Lichtenstein GR, Grandhi N, Schmalz M et al. Clinical trial: sodium phosphate tablets are preferred and better tolerated by patients compared to polyethylene glycol solution plus bisacodyl tablets for bowel preparation. Aliment Pharmacol Ther 2007; 26: 1361-1370
  • 9 Wruble L, Demicco M, Medoff J et al. Residue-free sodium phosphate tablets (OsmoPrep) versus Visicol for colon cleansing: a randomized, investigator-blinded trial. Gastrointest Endosc 2007; 65: 660-670
  • 10 Juluri R, Eckert G, Imperiale TF. Polyethylene glycol vs. sodium phosphate for bowel preparation: a treatment arm meta-analysis of randomized controlled trials. BMC Gastroenterol 2011; 11: 38
  • 11 Summary of product characteristics of Colokit. http://agence-prd.ansm.sante.fr/php/ecodex/rcp/R0167051.htm
  • 12 Lai EJ, Calderwood AH, Doros G et al. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc 2009; 69: 620-625
  • 13 Calderwood AH, Jacobson BC. Comprehensive validation of the Boston Bowel Preparation Scale. Gastrointest Endosc 2010; 72: 686-692
  • 14 Heresbach D, Boustière C, Coffin B et al. [Consensus en endoscopie digestive: préparation colique pour la coloscopie totale chez l'adulte]. Acta Endosc 2011; 41: 39-46
  • 15 SFED. 2 jours d'endoscopie en France. Resultat de l’enquête 2008. http://www.sfed.org/documents_sfed/files/mediatheque/2Jours_Endo_enFr_2008.pdf Accessed February 6, 2015
  • 16 Hassan C, Bretthauer M, Kaminski MF et al. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2013; 45: 142-150
  • 17 OsmoPrep summary of product characteristics UK. Date of revision: February 2013
  • 18 OsmoPrep prescribing information. Raleigh, North Carolina, USA: Salix Pharmaceuticals; 2012
  • 19 Barret M, Boustiere C, Canard JM et al. Factors associated with adenoma detection rate and diagnosis of polyps and colorectal cancer during colonoscopy in France: results of a prospective nationwide survey. PloS one 2013; 8: e68947
  • 20 Heresbach D, Boustiere C, Coffin B et al. Consensus in gastrointestinal endoscopy: preparation for full colonoscopy in 2011 [in French]. Acta Endosc 2011; 41: 145-152
  • 21 Heresbach D. What will 2013 bring in terms of bowel preparation before colonoscopy? Is form more important than substance?. Acta Endosc 2013; 43: 2-7
  • 22 Kastenberg D, Barish C, Burack H et al. Tolerability and patient acceptance of sodium phosphate tablets compared with 4-L PEG solution in colon cleansing: combined results of 2 identically designed, randomized, controlled, parallel group, multicenter phase 3 trials. J Clin Gastroenterol 2007; 41: 54-61
  • 23 Layton JB, Klemmer PJ, Christiansen CF et al. Sodium phosphate does not increase risk for acute kidney injury after routine colonoscopy compared with polyethylene glycol. Clin Gastroenterol Hepatol 2014; 12: 1514-1521
  • 24 Belsey J, Epstein O, Heresbach D. Systematic review: oral bowel preparation for colonoscopy. Aliment Pharmacol Ther 2007; 25: 373-384
  • 25 Coron E, Dewitte M, Aubert P et al. Reversibility of gastric injuries induced by sodium phosphate tablets. Endoscopy International Open 30.10.2014; DOI: 10.1055/s-0034-1377934.
  • 26 Schir E, Barbouy des Courières S, Plottin F et al. [Gastrite erosive sous preparation colique Colokit (phosphate monosodique et disodique)]. Therapie 2012; 67: 477-479